Seth Farbman on Podcast - From Startup to Stock Exchange Overnight' Success's Cost? 25 Years – Propanc Biopharma CEO’s 25 Year Grind | Seth Farbman’s Podcast
What if cancer could be turned from a killer into a manageable chronic illness with no hair loss, no nausea, and no immunosuppression?
In this gripping episode of Startup to Stock Exchange, host Seth Farbman goes deep with James Nathanielsz, CEO of NASDAQ-listed Propanc Biopharma (PPCB).
From a 17-year grind raising over $30M, battling economic crashes, COVID, and regulatory wars, to compassionate-use stories where terminal patients defied odds and lived years longer, James reveals the science behind their novel proenzyme therapy PRP.
Now NASDAQ-uplisted and gearing up for a landmark Phase 1b first-in-human trial in 2026 targeting advanced solid tumors like pancreatic and ovarian cancers, this could redefine treatment in massive markets.
A raw, no-BS conversation on biotech perseverance, integrity in public markets, patient hope, and a potential game-changer that started with one doctor's desperate fight to save lives.
Don't miss the underdog story that might just change everything.
Seth’s Companies
Vstock Transfer – https://www.vstocktransfer.com/
Share Media – https://www.sharemedia.co/
Listen to the Show
Apple Podcasts – https://podcasts.apple.com/us/podcast/seth-farbman-on-podcast-from-startup-to-stock-exchange/id1356667808
Spotify – https://open.spotify.com/show/54i7xkWaAALAFrUvk4WZcN
Connect with Seth
LinkedIn – https://www.linkedin.com/in/sethfarbman/
Instagram – https://www.instagram.com/sethfarbmanstock
TikTok – https://www.tiktok.com/@sethfarbman
Twitter (X) – https://x.com/sethfarbman1
About the Show
From Startup to Stock Exchange, hosted by entrepreneur and investor Seth Farbman, spotlights the journey of founders and CEOs as they scale their companies from early ideas to public markets. Each episode features candid conversations with leaders across industries, offering insights on growth, fundraising, branding, and the mindset it takes to build a company that lasts.
00:48 – Seth introduces James Nathanielsz & Propanc Biopharma (PPCB)
02:13 – Rambo scars analogy: 17+ years of entrepreneurial wars
03:08 – Propanc today: 17 years, $30M raised, NASDAQ uplist 2025
03:55 – Seth on the insane conviction needed for 17-year biotech grind
08:12 – Core motivation: helping families, belief the drug truly works
10:37 – Origin: 28-year-old mom gained 2 extra years via treatment
12:34 – 46 compassionate patients: 19 terminal cases beat huge odds, no side effects
15:26 – Vision: Turn metastatic cancer into a chronic illness game-changing
17:23 – “25 years of overnight success”
32:50 – Get treatment to patients fast, transformative potential
Connect with Seth
LinkedIn – https://www.linkedin.com/in/sethfarbman/
Instagram – https://www.instagram.com/sethfarbmanstock
TikTok – https://www.tiktok.com/@sethfarbman
Twitter (X) – https://x.com/sethfarbman1